Tetanus Prophylaxis — Wound Management

Key Points

• Classify the wound as clean/minor or dirty/major before deciding prophylaxis.
• Unknown vaccination history is managed as incomplete vaccination.
• After a complete primary series, clean minor wounds require a booster only if 10 or more years have elapsed.
• After a complete primary series, dirty or major wounds require a booster if 5 or more years have elapsed.
• TIG is never indicated for a clean minor wound.
• For dirty or major wounds, TIG is indicated when the primary series is incomplete or unknown and in selected severely immunocompromised patients.
• TIG dose for wound prophylaxis is 250 IU intramuscularly.
• Antibiotics are not used solely to prevent tetanus.
• Wound cleaning and debridement remain essential regardless of vaccination status.

Algorithm

1. Clean and inspect the wound; remove foreign material and devitalized tissue.
2. Classify the wound as clean/minor or dirty/major.
3. Determine whether at least three tetanus toxoid-containing doses were previously completed.
4. If vaccination history is unknown or incomplete, give an age-appropriate tetanus-containing vaccine for any wound.
5. For a dirty or major wound with incomplete or unknown vaccination, add TIG 250 IU IM.
6. If the primary series is complete, check time since the last tetanus-containing vaccine.
7. Give a booster at 10 years for clean minor wounds or 5 years for dirty/major wounds.
8. Use Tdap when appropriate if the patient has never received it or the history is uncertain.
9. Arrange completion of the vaccine series and document the date and product.

Clinical Synopsis & Reasoning

Tetanus prophylaxis is based on two questions: how tetanus-prone is the wound, and how complete and recent is the patient's tetanus vaccination? Clostridium tetani spores are widespread in the environment and can germinate in devitalized, poorly oxygenated tissue. Puncture wounds, penetrating injuries, wounds contaminated with soil, feces, or saliva, burns, crush injuries, frostbite, and wounds containing necrotic tissue are considered dirty or major wounds for prophylaxis decisions. Clean, minor wounds carry substantially lower risk.

The history must establish whether the patient completed a primary tetanus series, generally at least three appropriately spaced tetanus toxoid-containing doses, and when the last dose was given. A patient with an unknown history should be treated as incompletely vaccinated. For people who completed the primary series, no booster is needed for any wound if the most recent tetanus-containing vaccine was less than 5 years ago. For clean minor wounds, a booster is indicated when 10 or more years have elapsed. For dirty or major wounds, the booster interval is 5 years.

Tetanus immune globulin provides temporary passive antitoxin and is reserved for situations in which vaccine-induced protection is absent or unreliable. TIG is never indicated for clean minor wounds. For dirty or major wounds, give TIG to patients with unknown vaccination history, no prior tetanus vaccination, or an incomplete primary series. CDC guidance also recommends TIG for dirty or major wounds in people with HIV infection or severe immunodeficiency because vaccine response may be inadequate. Antibiotics should be used when needed to treat an actual wound infection, but they are not recommended solely to prevent tetanus.

Treatment Strategy & Disposition

All wounds should be cleaned promptly. Remove dirt and foreign material and debride obviously necrotic tissue. Evaluate for retained foreign body, tendon or neurovascular injury, fracture, bite-related infection, and the need for surgical management. Tetanus prophylaxis does not replace ordinary wound care.

When vaccination is indicated in a person age 7 years or older, Tdap is preferred if the patient has never received Tdap or the prior Tdap history is unknown; otherwise either Tdap or Td can be used according to the current immunization schedule. Patients with an incomplete primary series should receive the indicated dose at the visit and be scheduled to complete the remaining doses. For children younger than 7 years, use age-appropriate DTaP-based recommendations.

If TIG is indicated for a dirty or major wound, CDC recommends 250 international units intramuscularly. Give vaccine at the same visit but in a different syringe and different anatomic site. TIG neutralizes circulating toxin but does not provide durable immunity, so an incompletely immunized patient still needs vaccination. A patient who has previously had tetanus also requires vaccination because clinical disease does not reliably produce immunity.

Epidemiology / Risk Factors

• Tetanus is uncommon in the United States because of vaccination but persists in underimmunized populations.
• C. tetani spores are found in soil, dust, and animal intestinal contents and can persist in the environment.
• Older adults and people without a documented primary series account for a disproportionate share of cases.
• Tetanus is not transmitted person to person.
• A history of tetanus disease does not substitute for vaccination.

Investigations

Who Needs TIG?

Pharmacology

Prognosis / Complications

• Appropriate vaccination and TIG when indicated make wound-associated tetanus highly preventable.
• Once clinical tetanus develops, prolonged hospitalization and ventilatory support may be required.
• Risk is greatest in unvaccinated or incompletely vaccinated patients with contaminated or devitalized wounds.
• Timely debridement lowers the burden of tissue conditions that support spore germination.
• Completing the primary series after the acute visit provides durable future protection.

Patient Education / Counseling

• Explain whether the wound is considered tetanus-prone and why.
• Provide the exact date when the next vaccine dose is due if the series is incomplete.
• Clarify that TIG gives temporary protection and does not replace vaccination.
• Advise patients to return for increasing pain, redness, swelling, drainage, fever, or loss of function from the wound.
• Explain that antibiotics are prescribed for infection risk, not as a substitute for tetanus prophylaxis.
• Encourage routine decennial tetanus boosters so future wound decisions are simpler.

Notes

Tetanus prophylaxis errors usually come from confusing booster timing with TIG indications. TIG is not a stronger booster. It is passive antibody used when a high-risk wound occurs in someone who may not have reliable active immunity. Conversely, a fully immunized patient with a dirty wound usually needs only a booster if the last tetanus-containing vaccine was at least 5 years earlier.

The wound itself still deserves standard emergency evaluation. Prophylaxis does not address retained foreign body, devitalized tissue, bite-wound pathogens, fracture, tendon injury, or vascular compromise. Treat those problems on their own merits while updating tetanus protection.

References

1. CDC Clinical Guidance for Wound Management to Prevent Tetanus — Link
2. CDC Pink Book: Tetanus — Link